0001415889-24-008492.txt : 20240319 0001415889-24-008492.hdr.sgml : 20240319 20240319161008 ACCESSION NUMBER: 0001415889-24-008492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240316 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ferra Joseph J Jr CENTRAL INDEX KEY: 0001733790 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40523 FILM NUMBER: 24763273 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elevation Oncology, Inc. CENTRAL INDEX KEY: 0001783032 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 841771427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 FEDERAL STREET STREET 2: SUITE 1900 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7163711125 MAIL ADDRESS: STREET 1: 101 FEDERAL STREET STREET 2: SUITE 1900 CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: 14ner Oncology, Inc. DATE OF NAME CHANGE: 20190719 4 1 form4-03192024_040301.xml X0508 4 2024-03-16 0001783032 Elevation Oncology, Inc. ELEV 0001733790 Ferra Joseph J Jr C/O ELEVATION ONCOLOGY, INC. 101 FEDERAL STREET, SUITE 1900 BOSTON MA 02110 true true false false CHIEF EXECUTIVE OFFICER 0 Common Stock 2024-03-16 4 M 0 12562 A 90453 D Common Stock 2024-03-16 4 F 0 4773 4.39 D 85680 D Restricted Stock Unit 2024-03-16 4 M 0 12562 0 D Common Stock 12562 62809 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs vested on June 16, 2022, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. The RSUs do not expire; they either vest or are canceled prior to the vesting date. /s/ Robert Yang, Attorney-in-Fact 2024-03-19